Trials / Completed
CompletedNCT05987969
Efficacy and Safety of the Alena App as a Treatment for Social Anxiety Disorder
Efficacy, Tolerability and Safety of a Smartphone-delivered, Fully Automatic Cognitive Behavioural Therapy Programme for Social Anxiety
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Aya Technologies Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The present study is a randomised controlled trial that seeks to investigate the efficacy and safety of the Alena app as a treatment for social anxiety disorder.
Detailed description
This will be a 10-week web-based parallel-group unblinded randomised controlled trial with an 8-week intervention period and a 2-week follow-up post-intervention. Participants will be randomly allocated to receive access to the Alena app or to a wait list control group, in a 1:1 ratio. The Alena app primarily comprises CBT-based therapy for social anxiety based on the Clark and Wells model, as well as cognitive assessments, calming exercises and a community forum.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | "Alena" mobile application | This mobile application primarily comprises CBT-based therapy for social anxiety based on the Clark and Wells model, as well as cognitive assessments, calming exercises and a community forum. |
Timeline
- Start date
- 2023-03-20
- Primary completion
- 2023-06-07
- Completion
- 2023-06-07
- First posted
- 2023-08-14
- Last updated
- 2023-08-14
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05987969. Inclusion in this directory is not an endorsement.